Johnson & Johnson reports Q4 and Full-Year 2025 results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Johnson & Johnson (JNJ) Meets EPS Estimate, Beats on Revenue; Offers FY Guidance
January 21, 2026 6:22 AM EST(Updated - January 21, 2026 8:28 AM EST)
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.46, in line with the analyst estimate of $2.46. Revenue for the quarter came in at $24.6 billion versus the consensus estimate of $24.15 billion.
GUIDANCE:
Johnson & Johnson sees FY2026... More
